Companies Related to "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial" [Most Relevant Company Matches] - Page: 18 RSS

21:50 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial" found in our extensive corporate database of over 50,000 company records.

Showing "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial" Companies 426–450 of 5,400+

Probably Relevant

AMS Biotechnology (Europe) Limited

ImmunoKontact has been manufacturing and distributing high quality immunobiologicals for over a decade.Year after year we have constantly expanded the range of our antibodies, proteins and ELISA kits to include the latest analytes and developments...and this range is still growing: this is happening very much thanks to you, both as the demanding customer we have become familiar with as well as the...

Northern Light

Northern Light has been providing strategic research portals, business research content, and search technology to global enterprises since 1996. Northern Light's current clients include Fortune 100 market leaders in information technology, pharmaceuticals, telecommunications, energy, financial services and insurance, transportation, retailing, and electronics. Headquartered in Cambridge, Massac...

Ecija Abogados

Ecija Abogados, ranked number 17 in the Spanish Law Firms Global Ranking "Business Law in Spain, 2003-2005", Gaceta de los Negocios. In addition, Ecija Abogados occupies the first place in Bussines Growth and the fourth place in Social Establishment as in Human Capital and Organization.Likewise the guide selects the firm as the third in Intellectual Property and includes Hugo Ecija and Alvaro Ecij...

Ricoh Americas Corporation

Ricoh Americas Corporation, headquartered in West Caldwell, N.J., is a subsidiary of Ricoh Company, Ltd., the 74-year-old leading provider of advanced office technology and innovative document imaging products, services and software, with fiscal year 2009 sales in excess of $21 billion.


At Pharmex we found that to servive in the ever changing,ever demanding Health Care Profession required more than just being a "copycat" of others. Working at the side of pharmacists,year after year, Pharmex learned what tools dedicated professionals really needed to produce the growing millions of prescriptions. What's more, they learned how to produce them as quickly and accurately as possible.


Pro-Pharmaceuticals Inc. is a research leader in developing a new generation of Glyco-upgrade™ oncologic drugs. We target sugar-specific binding sites found on cancer cells using carbohydrate technology with the goal of improving efficacy and reducing toxicity of some of the proven, commonly used anti-cancer drugs.Two platforms of technologies have been identified by Pro- Pharmaceuticals. The fi...

JLL Partners and Royal DSM

JLL Partners is a middle-market private equity firm with a 25 year track-record of adding value to complex investments through financial and operational expertise. Since its founding in 1988 by Paul S. Levy, JLL Partners has committed approximately USD 4.2 billion across six funds, and developed significant expertise in the healthcare and other sectors....

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals is focused on neurodegenerative diseases that affect millions of patients worldwide. The company’s novel lead candidate NB-01 is a potential treatment for diabetic neuropathic pain. NB-01 increases levels of the neurotrophin, nerve growth factor (NGF). NGF inhibits nerve cell death and promotes nerve regeneration. The compound...

TransOral Pharmaceuticals, Inc

TransOral Pharmaceuticals, Inc., is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. The Company's initial proprietary technology is being employed to accelerate efficacy and reduce drug dose in the development of therapeutics for the treatment of migraine and insomnia.

Ra Pharmaceuticals, Inc.

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit:

J.P. Morgan Chase & Co.

J.P. Morgan is the investment banking arm of JPMorgan Chase & Co. (NYSE: JPM), a leading global financial services firm with assets of $2.3 trillion and operations in more than 60 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management...

IDA Ireland

IDA Ireland (Industrial Development Agency) is an Irish Government agency with responsibility for securing new investment from overseas in manufacturing and internationally traded services sectors. It also encourages existing investors to expand and develop their businesses. Over 1,050 overseas companies have chosen to invest in Ireland as their European base and are involved in a wide range of ac...

MN Pharmaceuticals

MN Pharmaceuticals Its founder Prof. Mustafa Nevzat Pisak played an important role in establishing contemporary pharmacy in Turkey, in changing the academic pharmacy program to one fashioned on Western methods, and in the development of Turkish Pharmaceutical Industry.His "Laboratory" is one of the first manufacturers of injectable ampoules in Turkey. With its 8 employees, the laboratory moved to ...

APP Pharmaceuticals, LLC

APP Pharmaceuticals is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, al...

UMB Financial Corporation

UMB Financial Corporation (NASDAQ: UMBF) is a financial services holding company headquartered in Kansas City, Mo., offering complete banking, asset management, health spending solutions and related financial services to commercial, institutional and personal customers nationwide. Its banking subsidiaries own and operate 128 banking centers throughout Miss...

First Niagara Financial Group

First Niagara Financial Group, Inc., through its wholly owned subsidiary, First Niagara Bank, N.A., has $21 billion in assets, 255 branches and $13 billion in deposits. First Niagara Bank is a multi-state community-oriented bank with about 3,800 employees providing financial services to individuals, families and businesses. Upon completion of its pending merger with NewAlliance Bancorp, Inc. -- su...

Strativa Pharmaceuticals

Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), excels at finding, enhancing, and bringing to market drugs that make a meaningful difference to patients. For more information about Strativa, visit

NemaRx Pharmaceuticals Inc

NemaRx Pharmaceuticals Inc. was incorporated in Calgary (Canada) in May 2003 and is part of the Inno-centre Alberta network. Using its proprietary screening technologies, NemaRx focuses on the building of a drug development pipeline centered around neurodegenerative disease indications as well as novel analgesics.

SPMJ Technology

We are an established independent technology consultancy based near Cambridge in the UKThe output of our efforts is usually a:Market Assessment Report Marketing StrategyBusiness PlanSystem SpecificationSystems Engineering Design

OSI Pharmaceuticals, Inc.

OSI Pharmaceuticals is committed to "shaping medicine and changing lives" by discovering, developing and commercializing high-quality, novel and differentiated targeted medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity. For additional information about OSI, please visit

CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc. is a China-based biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region.

Patient Safety Movement Foundation

More than 200,000 people die every year in U.S. hospitals in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, to reduce that number of preventable deaths to 0 by 2020 (0X2020). Improving patient safety will require ...

hameln pharmaceuticals ltd

hameln pharmaceuticals ltd are constantly striving to supply our customers with the best in service, reliability, and of course the finest quality injectable solutions. With over 30 years experience of supplying the NHS we have established a reputation for being one of the most reliable suppliers in the business.As part of the German group, hameln pharmaceuticals gmbh, we are backed by a company w...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the largest pharmaceutical company in Japan. Takeda Pharmaceuticals International, Inc. is the hub for R&D excellence and the commercial activities in Americas and Europe as well as other s...


We've combined these elements into a powerful performance solution that creates immediate value. If you're a healthcare financial executive, you're constantly under pressure to grow margins, increase cash, mitigate risk, and reduce costs. Many leading health systems - like Kaiser Permanente, Triad Hospitals, Partners Health System, Cedars-Sinai, Duke University, and Tenet Healthcare - have chosen ...

More From BioPortfolio on "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial"

Quick Search


Corporate Database Quicklinks